nomods.bsky.social
@nomods.bsky.social
This post is retarted
February 3, 2025 at 12:57 PM
Reposted
Goldman Sachs analysts : The money men saying the quiet part out loud

Curing patients may not be a sufficiently profitable enterprise for biotech companies.

Chronic disease is a far more beneficial business model

www.cnbc.com/2018/04/11/g...
Goldman Sachs asks in biotech research report: 'Is curing patients a sustainable business model?'
Goldman Sachs warns sales from the most successful disease treatments are difficult to maintain.
www.cnbc.com
December 18, 2024 at 10:48 AM
Is this just a place for shitposting or does anyone do any actual investigative journalism on here? Would love to read some interesting articles...recommendations?
December 16, 2024 at 6:02 PM